THE NUVISAN GROUP Continues Its Growth by Adding Parts of the GALDERMA R&D Capabilities from NESTLÉ SKIN HEALTH
On August 31st the NUVISAN GROUP, one of Europe´s leading CRO´s focused on early stage drug development for the life science industry, signed an agreement with NESTLÉ SKIN HEALTH/ GALDERMA to take over parts of the R&D capacities in Sophia-Antipolis, France.
The GALDERMA R&D site in Sophia-Antipolis which opened in 2006 is the world’s largest research and development center focused on medical and cosmetic solutions for the skin. The new capabilities will strengthen NUVISAN’S core service lines in Bioanalysis, Clinical Trial Supplies and Pharmaceutical Analytics as well as enhancing the portfolio by adding GMP-API synthesis and formulation capability for prescription drugs and cosmetics. NUVISAN intends to start its operations in Sophia Antipolis in October 2018.
NUVISAN thus underscores its claim to becoming Europe’s leading one-stop pharma services provider in the field of early stage drug development for the pharmaceutical industry with its third acquisition since 2011. The integration of parts of the former GALDERMA R&D will add 80 employees to NUVISAN's existing 325 employees to give 400+ employees in the NUVISAN GROUP.
"With these new R&D capabilities and capacities, we not only integrate a high-performance team, but also obtain access to a great deal of specialty know-how which we can bundle directly into the NUVISAN GROUP, enabling us to significantly increase and enhance benefits to our customers " says CEO of NUVISAN, Dr. Dietrich Bruchmann.
NUVISAN is now able to significantly accelerate the drug development process from discovery to clinical trials for clients.
With these new capacities, NUVISAN expertise will be extended to the fields of chemistry, liquid and semi-solid formulation development whilst creating an operational hub in close proximity to Southern European customers.
About NUVISAN
The owner-managed NUVISAN GROUP generates sales of approx. € 40 million with currently over 300 highly qualified employees. It originated from LAB AAI Pharma 40 years ago and has been operating under the name NUVISAN GmbH with its headquarters in Neu-Ulm since 2010. With the addition of the new R&D capacities, the headcount will increase by more than 20% and brings NUVISAN to app. 400+ employees.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180905005854/en/
Contact information
NUVISAN
Dr. rer. medic. David Surjo
Executive Vice President
Pharmaceutical Services
Phone: +49 731 9840 235 / +49 162 4061 836
Email:
david.surjo@nuvisan.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Curatis Expands Distribution Business With Phoenix Labs with up to CHF 5m Additional Annual Revenues5.9.2025 08:00:00 EEST | Press release
Curatis Holding AG (SIX: CURN, 'Curatis') announces a new distribution contract with Phoenix Labs (Ireland) for four products in Switzerland. Significant revenue growth with new products Curatis has signed a contract with Phoenix Labs (Ireland) to distribute four products in the areas of pain management and urology in Switzerland, starting from October 2025. These products generated revenues of approximately CHF 5 million in Switzerland in 2024. As the marketing authorisation holder, Curatis will be responsible for all regulatory, quality and pharmacovigilance services on behalf of Phoenix Labs in Switzerland. About Curatis: Curatis Holding AG is a publicly listed company (CURN.SW) specializing in the late stage development and commercialization of drugs for rare diseases and specialty care. Curatis has a sales portfolio of more than 40 products and a pipeline of orphan and specialist drugs. More information can be found on the website www.curatis.com. Disclaimer: The information conta
Zepp Health Acquires Core Assets of Wild.AI to Expand Support for Female Athletes Across Life Stages5.9.2025 01:42:00 EEST | Press release
Zepp Health (NYSE: ZEPP), the parent company of Amazfit, today announced it has acquired the core assets and intellectual property of Wild.AI, a pioneering women’s wellness platform focused on optimizing female performance through hormone-informed coaching. The acquisition was completed at the end of August and includes Wild.AI’s proprietary technology and select members of its leadership team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250904422306/en/ Zepp Health (NYSE: ZEPP), the parent company of Amazfit, today announced it has acquired the core assets and intellectual property of Wild.AI, a pioneering women’s wellness platform focused on optimizing female performance through hormone-informed coaching. Wild.AI is renowned for using physiological and hormonal data to help women Track, Train, Fuel, and Recover based on their cycle and life stage. From menstruation to menopause, the platform delivers personalized insigh
ProAmpac and Divilly’s Bring Recyclable Fibre Innovation to Meat Packaging4.9.2025 22:23:00 EEST | Press release
ProAmpac, a global leader in flexible packaging and material science, is proud to announce its collaboration with Galway-based Divilly Brothers to introduce ProActive Recyclable® FibreSculpt to the Irish chilled cooked meats market. This alliance reflects both companies’ shared commitment to delivering high-quality products in more environmentally responsible packaging. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250904134986/en/ Divilly Brothers use of ProAmpac's FibreSculpt Divilly Brothers, renowned for its heritage in crafting premium cooked and sliced meats, is taking a bold step forward with the launch of its new no added nitrite ham range. The new product will debut in high-barrier, kerbside recyclable FibreSculpt packaging. By adopting FibreSculpt, the company is significantly reducing plastic use while maintaining product protection, freshness, and a premium appearance on the shelf. “Quality has always been at th
500 Global and Creators HQ Partner to Incubate the Next Generation of Creator-Led Startups4.9.2025 17:25:00 EEST | Press release
500 Global, one of the world’s most active venture capital firms1, and Creators HQ, the first content creator hub in the UAE and the Middle East and part of Visioneers, today announced a strategic partnership to launch the Creators Ventures Accelerator, which identifies and incubates the most promising creator-led startups worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250904787040/en/ Her Excellency Alia AlHammadi, Vice Chairperson of the UAE Government Media Office and CEO of the 1 Billion Followers Summit with Courtney Powell, COO & Managing Partner, 500 Global. Focusing on supporting the creator economy - an industry projected to grow to $480 billion by 2027 - the inaugural cohort of the Creators Ventures Accelerator will include up to 20 high-potential creators and creator-enablers, who are ready to transform their ideas and influence into thriving, scalable ventures. "Creators are uniquely positioned to disr
ContourGlobal’s First Renewable Energy Facility in U.S. Comes Online in Colorado4.9.2025 17:22:00 EEST | Press release
ContourGlobal announced today the start of operations at Black Hollow Sun I (BHS I), a 185 MWp solar photovoltaic facility located near the Town of Severance, Colorado. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250904358284/en/ BHS I - ContourGlobal’s first operating renewable plant in the United States BHS I represents ContourGlobal’s first operating renewable plant in the United States and the initial phase of the Black Hollow Sun complex, which will also include BHS II (139 MWp). When fully completed in 2026, the power complex will reach a total capacity of 324 MWp, making it Northern Colorado’s largest solar project and Platte River’s largest contracted solar asset. Once fully operational, the complex will produce around 608 GWh of clean energy each year, which will be delivered to Platte River Power Authority, the community-owned utility serving Fort Collins, Loveland, Estes Park, and Longmont. This is enough clean
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom